| 摘要: |
| 目的:探讨家庭雾化吸入治疗毛细支气管炎的可行性,为临床治疗方式提供参考。方法:选取我院2015年1月至2016年1月在门诊诊断为轻/中度毛细支气管炎的患儿177例,按随机分组设计方案分为家庭组85例和医院组92例。两组患儿均采用压缩空气驱动的射流雾化器雾化吸入布地奈德混悬液及0.5%沙丁胺醇雾化溶液,家庭组由经过培训的家长在家中进行,医院组在医院门诊雾化室进行,两组患儿分别于治疗第3天、第5天及第7天监测其喘息缓解时间、喘鸣音消失时间、咳嗽消失时间、疗程、不良反应及家长满意度。结果:医院组总有效率为92.4%,高于家庭组的81.2%(P<0.05);医院组的喘息缓解时间及喘鸣音消失时间为(3.39±1.28)d、(4.01±1.29)d,家庭组喘息缓解时间及喘鸣音消失时间为(3.71±1.26)d、(4.35±1.37)d,两组比较差异有统计学意义(P<0.05);家长满意度中的方便性、依从性家庭组明显高于医院组(P<0.05),而可操作性、安全性、给药规律性三项指标及总满意度家庭组明显低于医院组(P<0.01)。结论:家庭雾化吸入治疗毛细支气管炎暂不可行,有待进一步观察。 |
| 关键词: 家庭雾化吸入 毛细支气管炎 可行性 |
| DOI：doi:10.13407/j.cnki.jpp.1672-108X.2017.10.005 |
|
| 基金项目::深圳市宝安区科技计划社会公益(医疗卫生类)项目,编号2015284 |
|
| Feasibility of Family Atomization Inhalation Therapy: Analysis of 85 Cases of Pediatric Bronchiolitis |
| Wu Zucheng, Lin Shiguang, Yan Nengrong, Li Jian爷an, He Ansheng |
| (Shiyan People's Hospital of Shenzhen, Guangdong Shenzhen 518108, China) |
| Abstract: |
| Objective: To explore the feasibility of family atomization inhalation therapy for pediatric bronchiolitis and provide evidence for clinical practice. Methods: One hundred and seventy-seven cases of mild to intermediate bronchiolitis diagnosed at our department from January 2015 to January 2016 were randomly assigned as 85 cases of family group and 92 cases of hospital group. Both groups used compressed air-driven atomizer to induce inhalation of budesonide and 0.5% salbutamol suspension. Drug administration of family group was carried out by trained parents at home and hospital group at outpatient pediatric department of our institute. Children in the two groups were followed-up at day 3, 5, 7 to monitor the time of gasping remission, wheezing disappearing, coughing disappearing, course of treatment, adverse reactions and satisfaction of parents. Results: Total effective rate of hospital group and family group were 92.4% and 81.2% (P<0.05). The time of gasping remission and wheezing disappearing were significantly different between two groups, the hospital group were (3.39±1.28) d and (4.01±1.29) d, the family group were (3.71±1.26) d and (4.35±1.37)d (P<0.05). Family group presented higher satisfaction with better compliance (P<0.05). While the operability, safety and regularity were significantly lower in the family group than those in the hospital group (P<0. 01). Conclusion: It is not feasible to treat bronchiolitis with family atomization inhalation, which needs further observation郾 |
| Key words: family atomization inhalation bronchiolitis feasibility |
